Musk to launch deadly bacteria:-Thomas g for microgravity experiments, germs, Tesla-IT information
Original title: Thomas g intends to launch deadly bacterium, and it may be to save life on Earth, IT edit modify, as necessary, of information.
This Valentine's day may not be a normal Valentine's day. On February 14, Silicon Valley's "iron man," Mr MASKEY plans, with their own commercial space exploration company SpaceX, orbital launch deadly superbugs.
Do not want to use this Superbug to destroy the space, but the bacteria back to the microgravity environment of the international space station (ISS) to experiment.
This Superbug scientific name for Methicillin-resistant Staphylococcus aureus, known as MRSA. It can lead to very frequent and difficult to treat infections in patients. The key point is that the bacteria rapidly become resistant to most antibiotics. SpaceX wants to do is hope that space travel could change this situation. After the successful launch, MRSA will be carried out in near-zero gravity experiments to see whether the weight loss would the bacteria gene and mutation rates have an impact.
According to the Forbes report, the study by the US National Aeronautics and Space Administration (NASA) and the space science center (CASIS). By then, the rocket launch, SpaceX will use its Falcon 9th the bacteria into space, and its national laboratory experiments in the international space station.
Nanobiosym company equipment, and teams responsible for specific experiments. The XPRIZE technology provided by the company, which is the world's first mobile "tricorders" equipment, used genetic fingerprints in real time diagnosis of any disease, and 10 times cheaper than the diagnostic tests currently on the market.
Chairman and CEO of Nanobiosym Annita·Geer (Anita Goel) thought that the near-zero gravity environment can lead to MRSA accelerated mutation. In other words, human beings can press the "fast forward" button to get on Earth undiscovered potential mutation mode.
"We work in the micro-gravity of the international space station is practical, Basic. We hope to promote the development of personalized, accurate medical, you can better predict drug resistance of bacteria in order to find better treatments. In the basic science level, I am eager to test the assumption that I was 20 years ago: the environment can profoundly affect genome and transcriptome information flow. "Gore says.
At this stage, the research team did not know MRSA will respond to how the new environment. Space bacteria but previous research experience, can cause mutations and population trend of above, will only speed differences.
Reason is simple: in the environment of space, some associated with the metabolism of proteins will become more active, while low doses of radiation can change the activity of certain genes.
If the experiment is successful, it will have an enormous impact on drug development. Because the current antimicrobial therapy is often ineffective, and the researchers did not know in advance the bacteria resistance only late in a real-time environment, or reviews can be found.
Gore and her team hope that the unique environment of space can allow them to observe the activity of MRSA, as changes may occur on the Earth reference. These data can be used to advance drug development and help researchers find a way to combat on Earth.
马斯克欲向太空发射致命病菌：为进行微重力实验 - 马斯克,病菌,特斯拉 - IT资讯
原标题：《马斯克打算向太空发射致命病菌，而它可能会拯救地球上的生命》，IT资讯编辑酌情修改。
今年的情人节可能不会是一个普通的情人节。2月14日，硅谷“钢铁侠”马斯克计划，用自家的商用太空探索技术公司SpaceX，向太空轨道发射致命的超级病菌。
这样做并不是想用这种超级病菌来毁灭太空，而是希望将病菌送到微重力环境下的国际空间站（ISS）进行实验。
这种超级病菌学名为耐甲氧西林金黄色葡萄球菌，也称为MRSA。它会引起病人非常频繁且难以治疗的感染。关键的一点是，这种病菌正在迅速变得对大多数的抗生素具有耐药性。SpaceX这次想做的就是希望太空旅行能改变这样的情况。发射成功过后，MRSA将在近零重力的情况下进行实验，看失重的情况是否会对这种病菌的基因和突变率产生影响。
根据《福布斯》的报道，这项研究由美国国家航空和宇宙航行局（NASA）和美国空间科学促进中心（CASIS）赞助。届时，SpaceX将用自己的猎鹰9号火箭发射这种病菌进入太空，并让其在国际空间站的国家实验室里进行实验。
具体的实验设备和团队由Nanobiosym公司负责。该公司提供了XPRIZE技术，这是世界上第一台移动的“三录仪”设备，能用基因指纹实时诊断任何疾病，而且比目前市场上的诊断测试要便宜10倍。
Nanobiosym公司董事长兼首席执行官安妮塔·戈尔（Anita Goel）认为，近零重力环境可能导致MRSA加速变异。换句话说，人类可以按下“快进”键，从而获得在地球上尚未发现的潜在突变模式。
“我们在微重力国际空间站的工作非常实用、基础。我们希望推进个性化、精准医疗的发展，可以更好地预测病菌的耐药性，从而找到更好的治疗药物。在基础科学层面上，我热衷于测试我20年前的假设：即环境可以深刻地影响基因组和转录组的信息流。”戈尔说。
在目前的这个阶段，研究团队还不知道MRSA会对新环境做出怎样的反应。但根据以前的太空细菌研究经验，环境会导致上述的基因突变和种群趋势，只是会有速度上的不同。
原因也很简单：在太空环境中，一些与新陈代谢相关的蛋白质会变得更加活跃，而低剂量的空间辐射也可以改变某些基因的活性。
如果实验成功，这将对药物发展产生巨大的影响。因为当前的抗菌疗法通常都是无效的，并且研究人员并不能提前了解病菌的耐药性，只有在实时环境或者是后期回顾时才能发现。
戈尔和她的团队希望太空独特的环境能让他们观察MRSA的活性，作为地球上可能会发生变化的参照。这些数据可用于提前的药物开发，并帮助地球上的研究人员找到有效对抗的方法。